Log In Get Started
Press Releases March 31, 2026

Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

Carlsmed to Present at 25th Annual Needham Virtual Conference, Showcasing AI-Enabled Spine Surgery Innovations

By Ajmal Hussain CARL
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
CARL

Carlsmed, Inc., a medical technology company specializing in AI-driven personalized spine surgery solutions, announced that CEO Mike Cordonnier will present at the 25th Annual Needham Virtual Conference on April 13, 2026. The presentation aims to highlight the company's mission to improve spine surgery outcomes and reduce healthcare costs. A live webcast and subsequent replay will be available for registered participants.

Key Points

  • Carlsmed focuses on AI-enabled personalized spine surgery solutions.
  • CEO to present company’s vision and innovations at a major investor conference.
  • The event provides increased visibility to potential investors and partners in the medical technology sector.

CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham Virtual Conference on April 13, 2026 at 11:45 AM ET.

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/cCMfZsH5ZqrwSNTwfC9JDv/RczDxtnmshQKpi2ivHQcH3

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


Risks

  • Market adoption of AI-enabled spine surgery technologies remains uncertain, impacting growth potential.
  • Competition within the medical technology and healthcare innovation sectors could affect market share.
  • Regulatory and reimbursement challenges in healthcare may influence the commercial success of Carlsmed’s solutions.

More from Press Releases

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders Apr 3, 2026 Midland States Bancorp, Inc. To Announce First Quarter 2026 Financial Results On Thursday, April 23 Apr 3, 2026 Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 3, 2026 Multi-Sensor Data Labeling and AI Data Operations: What Enterprise AV Teams Apr 3, 2026 Wix Announces Final Results of Modified Dutch Auction Tender Offer Apr 3, 2026